Rapport Therapeutics

Engrail Therapeutics

This company develops small-molecule therapies for patients with neurologic, neuropsychiatric and neurodevelopmental disorders such as anxiety, depression and rare diseases.

NeuroRX

This company develops small molecule medicines for patients with central nervous system disorders, such as suicidal bipolar depression and post-traumatic stress disorder.

Neumora Therapeutics

This biopharmaceutical company develops medicines for patients with neuropsychiatric disorders and neurodegenerative diseases.

Synendos Therapeutics

This company develops small molecule inhibitors to treat patients with central nervous system disorders, such as anxiety and post-traumatic stress disorder.

Engrail

This clinical-stage pharmaceutical company develops targeted small-molecule medicines for patients with neuropsychiatric and neurodevelopmental disorders.

IAMA Therapeutics

This company develops small molecule drugs to treat neurodevelopmental and central nervous system disorders for patients with autism and epilepsy.

Autobahn Therapeutics

This company develops brain-penetrating small molecule therapies for patients with neuropsychiatric and neuroimmunologic disorders, including depression and multiple sclerosis.

Neurosciences

This company develops precision sodium channel therapeutics to treat patients with neurological conditions such as genetic epilepsy and chronic neuropathic pain.